# Radiobiological and Clinical Advantages of Proton Therapy in Modern Cancer Treatment

## TL;DR

Proton therapy offers precise cancer treatment by delivering high radiation doses to tumors while minimizing damage to healthy tissues, with added biological advantages over traditional methods.

## Contribution

This review highlights the unique physical and biological advantages of proton therapy and its evolving technologies for improved cancer treatment outcomes.

## Key findings

- Proton therapy reduces acute and late toxicities compared to photon-based radiotherapy, especially in pediatric patients and tumors near critical organs.
- Protons cause complex DNA damage that is harder for cancer cells to repair, enhancing treatment effectiveness.
- Emerging technologies like FLASH proton therapy and pencil beam scanning are improving treatment precision and biological effectiveness.

## Abstract

A key advantage of protons is their ability to stop at a defined depth inside the body, allowing high radiation doses to be delivered to tumors while reducing damage to surrounding healthy tissues. In addition to these physical benefits, protons produce more complex damage within cancer cells, particularly near the end of their path, which can make tumors harder to repair and more sensitive to treatment. This review summarizes current knowledge on the physical principles, biological effects, and clinical outcomes of proton therapy and compares it with modern photon-based techniques. Emerging developments, including advanced beam delivery, integration with imaging and artificial intelligence, and ultra-high dose rate (FLASH) proton therapy, highlight the growing role of proton therapy as a precise, biologically effective, and evolving modality in cancer care.

Background/Objectives: Proton therapy has emerged as an advanced radiotherapy modality due to its unique physical dose distribution and its distinct radiobiological properties. The finite range of protons in tissue enables highly conformal dose delivery with minimal exit dose, significantly reducing irradiation of surrounding normal tissues compared to photon-based radiotherapy. Beyond these physical advantages, proton beams exhibit a spatially varying linear energy transfer that increases toward the distal edge of the spread-out Bragg peak, leading to clustered and complex DNA damage that is more difficult for cancer cells to repair. Methods: This review integrates experimental, computational, and clinical evidence to examine how proton-induced DNA damage, relative biological effectiveness, oxygen effects, and non-targeted responses contribute to tumor control and normal tissue sparing. Results: Comparative analyses with photon intensity-modulated radiotherapy demonstrate consistent reductions in acute and late toxicities across multiple tumor sites, particularly in pediatric patients and in tumors located near critical organs. The review also discusses emerging technologies, including pencil beam scanning, image-guided and adaptive proton therapy, compact accelerator systems, and ultra-high dose rate FLASH proton therapy, which collectively aim to enhance treatment precision, biological effectiveness, and accessibility. Conclusions: Together, these developments support proton therapy as a rapidly evolving modality with significant potential to improve therapeutic outcomes in modern oncology.